Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Hepatology
Endocrinology
Questions discussed in this category
Is the Enhanced Liver Fibrosis (ELF) test superior to the FIB-4 test in the diagnosis of MASLD?
3 Answers available
What is your approach on the pursuit of bariatric surgery in a patient with advanced fibrosis?
1 Answer available
Can fatty liver disease present with elevations in alkaline phosphatase without other liver enzyme elevations (AST and ALT)?
1 Answer available
Do you recommend the use of SGLT2 inhibitors to reduce the risk of liver cirrhosis in patients with Type 2 diabetes mellitus?
1 Answer available
25726
23702
24483
22838
Papers discussed in this category
International journal of molecular sciences, 2022 Mar 13
SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection.
Related Topics in Hepatology
Gastroenterology
General Hepatology
Transplant Hepatology
Metabolic Dysfunction-Associated Liver Diseases
Portal Hypertension
Autoimmune Liver Disease
Viral Hepatitis
General Hospital Medicine
General Internal Medicine
Alcohol-associated Liver Disease